Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.

概要

Correction to: Relationship between retinal
fluid and visual acuity in patients with
exudative age-related macular degeneration
treated with intravitreal aflibercept using a
treat-and-extend regimen: subgroup and
post-hoc analyses from the ALTAIR study.
著者

journal or
publication title

year
URL

OHJI Masahito, OKADA Annabelle Ayame, SASAKI
Koji, MOON SungChul Charles, MACHEWITZ
Tobias, TAKAHASHI Kanji
Graefe's archive for clinical and experimental
ophthalmology = Albrecht von Graefes Archiv
fur klinische und experimentelle
Ophthalmologie
2022-04-02
http://hdl.handle.net/10422/00013281

doi: 10.1007/s00417-022-05621-w(https://doi.org/10.1007/s00417-022-05621-w)

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits
use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
licence, and indicate if changes were made. The images or other third party material in this article
are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to

Graefe's Archive for Clinical and Experimental Ophthalmology
https://doi.org/10.1007/s00417-022-05621-w

CORRECTION

Correction to: Relationship between retinal fluid and visual acuity
in patients with exudative age‑related macular degeneration treated
with intravitreal aflibercept using a treat‑and‑extend regimen:
subgroup and post‑hoc analyses from the ALTAIR study
Masahito Ohji1 · Annabelle A. Okada2 · Koji Sasaki3 · SungChul Charles Moon3 · Tobias Machewitz4 ·
Kanji Takahashi5 · on behalf of the ALTAIR Investigators

© The Author(s) 2022

Correction to: Graefe’s Archive for Clinical and Experimental Ophthalmology (2021) 259:3637–3647
https://doi.org/10.1007/s00417-021-05293-y
The original version of this article unfortunately contained errors. The corrections are given in the following list:

The correct figure and legend are shown below. Revisions
are shown in green for ease of reference.
This is being corrected in this publication.

1. In Fig. 5A, the patient group with “Any fluid” at the
non-foveal location incorrectly also included a few
patients whose fluid presence is unknown. The corresponding non-foveal data have been re-evaluated and
Fig. 5A amended. Specifically, data for the number of
patients, mean BCVA, and 95% confidence intervals
have been updated for the bars representing non-foveal
fluid at weeks 16, 52, and 96. The correct data are now
presented in Fig. 5A.
2. In Fig. 5, it was also not specified that the footnotes
“Missing for each fluid compartment (n = 2)” and
“Unknown for IRF (n = 3)” were at baseline (not at other
timepoints). The Fig. 5 footnote has now been corrected
to clarify that these cases were at baseline.

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://​creat​iveco​mmons.​org/​licen​ses/​by/4.​0/.

Publisher's note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.

The original article can be found online at https://​doi.​org/​10.​1007/​
s00417-​021-​05293-y.
* Masahito Ohji
eye.ohji@gmail.com
1



Department of Ophthalmology, Shiga University of Medical
Science, Shiga, Japan

2



Department of Ophthalmology, Kyorin University School
of Medicine, Tokyo, Japan

3

Bayer Yakuhin Ltd., Osaka, Japan

4

Bayer AG, Berlin, Germany

5

Department of Ophthalmology, Kansai Medical University,
Osaka, Japan





13

Vol.:(0123456789)



Fig. 1  Mean absolute BCVA (ETDRS letters) and 95% confidence
intervals at mandatory study visits at weeks 0, 16, 52, and 96 in A
patients without or with any foveal or non-foveal fluid,a B patients
without or with any foveal or non-foveal IRF, C patients without or
with any foveal or non-foveal SRF, and D patients without or with
any foveal or non-foveal PED. Full analysis set (N = 246).b,c The

13

Graefe's Archive for Clinical and Experimental Ophthalmology

number underneath each bar represents the number of patients in
each group at each study visit. aIncludes IRF and SRF only; bMissing for each fluid compartment at baseline  (n = 2); cUnknown for
IRF at baseline (n = 3). ...

この論文で使われている画像